Dorbala, Sharmila
- Brigham and Women's Hospital · Internal Medicine (topic-inferred)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #10,920
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$949K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#10,920
By linked amount among FY2023 PIs
Earliest Year Loaded
2009
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Dorbala, Sharmila as a PI. Multi-PI records show the full award amount for context.
- 5R01HL150342-04R01Contact PIEarly Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late LifeBrigham and Women's Hospital · Internal Medicine (topic-inferred)$827.5Kaward amount
- 5K24HL157648-03K24Contact PIMentoring Patient Oriented Research in Innovative Imaging and High-dimensional Data Approaches to Improve Outcomes in Cardiac AmyloidosisBrigham and Women's Hospital · Internal Medicine (topic-inferred)$121.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Dorbala, Sharmila as a PI.
FY2023 award administered by Brigham and Women's Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardBrigham and Women's Hospital
- 2012$500K Cumulative Funding
- 2013R01 Grant Holder
- 2016$1M Cumulative Funding
- 2016Entered Top 50% NationallyRanked #8160
- 2017$2M Cumulative Funding
- 2020$5M Cumulative Funding
- 2020Entered Top 25% NationallyRanked #2711